Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PS 16:1_17:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004002 AN006601 A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines Extracellular vescicles Human Cancer European Molecular Biology Laboratory LC-MS
ST004002 AN006601 A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines Extracellular vescicles Mouse Cancer European Molecular Biology Laboratory LC-MS
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003694 AN006060 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003637 AN005974 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003341 AN005476 Untargeted Lipidomic Profiling of Canine Cancer Cell Lines Cultured cells Dog Cancer Kojin Therapeutics, Inc. LC-MS
ST001267 AN002104 Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism Tongue Human Cancer University of Helsinki MS(Dir. Inf.)
  logo